Daily non-political popular news in brief.
New system for classifying infant lung disease developed
11-30-2007 · EurekAlert!A new classification system of rare lung diseases in infants is improving diagnosis and treatment. The system clears up considerable confusion about how to classify and treat diseases that are rarely seen by most doctors and pathologists, says Gail H. Deutsch, MD, lead author of the multi-center study that developed the new guidelines.
Read more »
Keywords: system, classifying, infant, lung, disease, developed
« Previous | Next »
Similar news on "New system for classifying infant lung disease developed":
- Newly discovered proteins associated with cystic fibrosis
11-03-2006 · EurekAlert!
Researchers have found a highly unusual distribution of proteins in the lungs and airways of people with cystic fibrosis. The discovery is preliminary, but intriguing: Finding out more about the proteins could help sort out the immune system's role in the disease. The study will be presented at a meeting of the American Physiological Society, "Physiological Genomics and Proteomics of Lung Disease," on Nov. 3.
Similar news · Read more »
- Pancreatic cancer vaccine halts progression of disease in some patients
04-17-2007 · EurekAlert!
A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
Similar news · Read more »
- New algorithms classify outcomes of nonsmall cell lung cancer patients
06-05-2007 · EurekAlert!
Two research teams have developed models for classifying the clinical outcomes of patients with nonsmall cell lung cancer using mass spectrometry techniques. The studies are published in the June 6 Journal of the National Cancer Institute.
Similar news · Read more »
- No carrier necessary: This drug delivers itself
03-14-2007 · EurekAlert!
The problem of efficiently delivering drugs, especially those that are hydrophobic or water-repellant, to tumors or other disease sites has long challenged scientists to develop innovative delivery systems that keep these drugs intact until reaching their targets. Now scientists in the University at Buffalo's Institute for Lasers, Photonics and Biophotonics and Roswell Park Cancer Institute have developed an innovative solution in which the delivery system is the drug itself.
Similar news · Read more »
- New guideline for treating Lyme disease
05-23-2007 · EurekAlert!
A guideline developed by the American Academy of Neurology finds conventionally recommended courses of antibiotics are highly effective for treating nervous system Lyme disease. However, there is no compelling evidence that prolonged treatment with antibiotics has any benefit in treating symptoms that persist following standard therapy. The guideline is published May 23, 2007, in the online edition of Neurology, the scientific journal of the American Academy of Neurology.
Similar news · Read more »
- 'GreeneChip' -- New diagnostic tool that rapidly and accurately identifies multiple pathogens
12-06-2006 · EurekAlert!
Researchers in the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health and their colleagues in the WHO Global Laboratory Network have developed a new tool for pathogen surveillance and discovery -- the GreeneChip System. The GreeneChip is the first tool to provide comprehensive, differential diagnosis of infectious diseases, including those caused by viruses, bacteria, fungi or parasites.
Similar news · Read more »
- Weak immune response critical to disease that causes most infant hospitalizations
04-05-2007 · EurekAlert!
For the past four decades, medical science thought it knew how severe RSV infections arose. Scientists blamed an overreaction in the lungs by specific immune-system cells, T lymphocytes (also known as "T cells"), for the most drastic symptoms of infection. But now, researchers have shown that severe RSV infections in the lower respiratory tract actually are associated with an inadequate immune reaction -- a characteristic they share with fatal influenza infections.
Similar news · Read more »
- UAB research could improve the prognosis and treatment of lung cancer
01-07-2008 · EurekAlert!
A group of scientists at the Universitat Autтnoma de Barcelona, has published research on an enzyme that is detected in large quantities only in lung cancers. This enzyme can appear even when the cancer has not yet developed. Thus this molecule would serve as a good marker in the diagnosis and prognosis of the disease. The research is of great interest for potential future therapeutical applications as well.
Similar news · Read more »
- Geisinger scientist seeks cure for Lou Gehrig's disease, creating device to find treatment
07-30-2007 · EurekAlert!
Geisinger Health System researcher Glenn Gerhard is seeking a cure for a devastating neurodegenerative condition, amyotrophic lateral sclerosis, or Lou Gehrig's disease. A cure -- or perhaps a treatment -- might be found in the right mix of the millions of drugs and drug compounds developed in laboratories across the world. With the help of some college students, Gerhard is designing a device to efficiently test those compounds. And that's bringing us closer to a cure.
Similar news · Read more »
- A potential biological cause for sudden infant death syndrome
10-31-2006 · EurekAlert!
New autopsy data provide the strongest evidence yet that sudden infant death syndrome (SIDS) is not a "mystery" disease but has a concrete biological basis: abnormalities in the brainstem serotonin system. Based on their findings, published in the November 1 issue of JAMA, researchers at Children's Hospital Boston now hope to develop a diagnostic test to identify newborns at risk, and envision treatments to protect them during the vulnerable period.
Similar news · Read more »
